Try GOLD - Free
RPG Life Sciences looks to enter India's GLP-1 market
Business Standard
|December 13, 2025
RPG Life Sciences is planning to enter India’s fast-emerging GLP-1 diabetes and obesity drug space, while keeping the US market on a medium-term acquisition-led radar, as it eyes ₹2500 crore turnover by 2030.
With a new managing director (MD) at the helm, the RPG Group arm is also doubling down on domestic branded formulations, sharpening its specialty focus, apart from building capacities in the active pharmaceutical ingredients (API) space through acquisitions.
“We have created a strategic vision built around five pillars, with building big, scalable brands at the core,” said Ashok Nair, MD, RPG Life Sciences. Nair, a pharma industry veteran having worked in Abbott, Cipla and Torrent Pharma, is consciously stepping away from crowded mass-market therapies to focus on super-specialty segments where clinical depth, complex prescribing behaviour and long treatment cycles support durable branding.
“The promoter vision is clear: To make RPG Life Sciences a flagship company of the group.” Nair told Business Standard.
The firm posted ₹582.1 crore revenue in 2024-2025 (FY25), up 13.5 per cent year-on-year (Yo-Y). In Q2FY26, RPG Life Sciences revenue from operations touched ₹181.7 crore, up 5.5 per cent.
This story is from the December 13, 2025 edition of Business Standard.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Business Standard
Business Standard
The army’s battle within
Women may be marching perfectly in parades but they are still denied the opportunity to serve in combat roles in the Indian Army
6 mins
December 16, 2025
Business Standard
DGCA probe panel on flight disruptions visits IndiGo HQ
The four-member panel, set up by Director General of Civil Aviation Faiz Ahmed Kidwai to investigate largescale operational disruptions at domestic carrier IndiGo earlier this month, visited the airline's headquarters on Monday as part of the ongoing probe, sources said.
1 min
December 16, 2025
Business Standard
Market sees fewer wild swings in H2CY25
Indian equity markets have moved from turbulence to relative calm this year.
2 mins
December 16, 2025
Business Standard
₹ hits new low for 3rd straight session
The rupee hit a new low for a third consecutive trading session on Monday, touching an intraday low of 90.80 per dollar, as uncertainty surrounding the India-US trade deal continued to weigh on the domestic currency, dealers said.
1 min
December 16, 2025
Business Standard
Proposed nuclear energy Bill caps operator's liability at ₹3,000 cr
The government on Monday introduced in Parliament a Bill that seeks to finally open up the Indian civil nuclear energy sector to private sector players, except in uranium mining, after amending specific provisions dealing with thorny issues like the supplier's liability and compensation in case of a nuclear accident.
2 mins
December 16, 2025
Business Standard
Film director Rob Reiner, wife found dead; son arrested
Actor who went on to direct classic films
2 mins
December 16, 2025
Business Standard
States may shoulder 40% of rural job plan funding
Slowing MGNREGA demand
5 mins
December 16, 2025
Business Standard
Exports grow fastest in nearly 3.5 years
Shipments to US, China rose sharply in Nov; gold imports shrank
1 mins
December 16, 2025
Business Standard
ICICI Pru AMC IPO booked 2x on Day 2 of bidding
ICICI Prudential AMC's mega initial public offering (IPO) was subscribed around two times on second day of bidding.
1 min
December 16, 2025
Business Standard
India-US framework trade deal soon: Commerce secy
India and the United States (US) are hoping to finalise a framework trade agreement “soon”, Commerce Secretary Rajesh Agrawal said on Monday.
3 mins
December 16, 2025
Listen
Translate
Change font size